NCT05939063Recruiting
LRAMPS Versus LDP in Selected Early-stage Left-sided Pancreatic Cancer
Laparoscopic Radical Antegrade Modular Pancreatosplenectomy Versus Laparoscopic Distal Pancreatosplecnectomy in Selected Left-sided Pancreatic Cancer: a Multicenter Randomized Controlled Clinical Trial
Source: ClinicalTrials.gov · Last updated 24 Nov 2023 · Not updated for over 12 months - ask the site whether it is still open
Brief summary (registry, in English)
This multicenter randomized controlled clinical trial proposed the criteria for selecting patients with early-stage left-sided pancreatic cancer and aimed to compare the perioperative and oncological outcomes of patients within the criteria who underwent laparoscopic radical antegrade modular pancreatosplenectomy versus laparoscopic distal pancreatosplenectomy.
- Status (registry)
- Recruiting
- Study type
- Interventional
- Enrollment
- 160 (estimated)
- First submitted
- 2 Jul 2023
- Start date
- Oct 2023
- Primary completion date
- Aug 2025
- Lead sponsor
- Fudan University
- Diseases
- Pancreatic cancer
- NCT number
- NCT05939063
What you commit to
- Study type: Interventional
- Planned participants: 160
- From Oct 2023 to the primary completion date, Aug 2025
- 1 site in 1 country
- Visits and tests: ask the trial team, the registry does not list them
Built from the registry fields of ClinicalTrials.gov. It describes the study, not your situation.
Who cannot take part
Copied verbatim from ClinicalTrials.gov and grouped by topic. Only the trial team decides who can take part.
Prior treatment
- Received neoadjuvant therapy.
Other illness
- Multifocal or recurrent disease.
- History of other malignancies.
Other
- Presence of liver or other distant metastasis.
- Simultaneously participating in other clinical trials.
Who the study is looking for
- Clinically diagnosed as resectable left-sided pancreatic cancer before surgery.
- Imaging tumor diameter ≤ 4 cm.
- Located ≥ 1cm from the celiac trunk.
- Tumor didn't invade the fascial layer behind the pancreas.
- Be able to comply with research protocol.
- Voluntary participation and signed informed consent.
Age in the registry: 18 years to 80 years · Sex: All · Does not accept healthy volunteers
Sites (1)
Sites in registry order. Pick your city on the disease page to sort them by distance.
| Site | City | Country | Site status |
|---|---|---|---|
| Department of Pancreatic Surgery,Fudan University Shanghai Cancer Center Coordinator of this site? Confirm its status | Shanghai | China | Recruiting |
This page is information, not medical advice. Discuss any trial with your doctor.